characteristics.text: Y132F+G307A
characteristics.characteristic: Erg11 Genotype
characteristics.text: SAMN41569566
characteristics.characteristic: External Id
characteristics.text: W1370R
characteristics.characteristic: Fks1 Genotype
characteristics.text: Conway Institute, University College Dublin
characteristics.characteristic: INSDC center name
characteristics.text: 2024-05-28T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-05-28T13:01:12.093Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS21446508
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Pathogen.cl
characteristics.characteristic: NCBI submission model
characteristics.text: Pathogen.cl.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS21446508
characteristics.characteristic: SRA accession
characteristics.text: Ege University Hospital, Turkey
characteristics.characteristic: collected_by
characteristics.text: 2022-09-28/2022-10-04
characteristics.characteristic: collection_date
characteristics.text: Turkey: Ege
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.characteristic: host
characteristics.text: Invasive candidiasis
characteristics.characteristic: host_disease
characteristics.text: A 14-month-old female patient was referred to the EUH with respiratory stress syndrome on September 28, 2022. Four months earlier she underwent complete correction of tetralogy of Fallot, atrial septal defect repair, and tracheostomy. Upon hospitalization at the EUH, tracheal aspirate swabs, bronchoalveolar lavage (BAL) fluid, and blood cultures were taken on September 28, 2022. The tracheal aspirate and BAL samples were positive for Acinetobacter baumanii, and a blood culture was positive for C. parapsilosis. Accordingly, gentamycin and caspofungin were started. Subsequent blood cultures taken on October 4, 2022, were again positive for C. parapsilosis; therefore, caspofungin was discontinued, and liposomal amphotericin B was added and continued until October 26, 2022. All the blood cultures taken during liposomal amphotericin B therapy were negative for C. parapsilosis, and the patient was discharged on November 1, 2022.
characteristics.characteristic: isolate
characteristics.text: blood sample
characteristics.characteristic: isolation_source
characteristics.text: 38.4567 N 27.2099 E
characteristics.characteristic: lat_lon
characteristics.text: Candida parapsilosis
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_5480
characteristics.characteristic: organism
characteristics.text: MDR7
characteristics.characteristic: strain
characteristics.text: Pathogen: clinical or host-associated sample from Candida parapsilosis
characteristics.characteristic: title